Kristen L. Park

Learn More
OBJECTIVE To advance the understanding of KCNQ2 encephalopathy genotype-phenotype relationships and to begin to assess the potential of selective KCNQ channel openers as targeted treatments. METHODS We retrospectively studied 23 patients with KCNQ2 encephalopathy, including 11 treated with ezogabine (EZO). We analyzed the genotype-phenotype relationships(More)
Supplemental data at Neurology.org/ng KCNQ2 encephalopathy Features, mutational hot spots, and ezogabine treatment of 11 patients ABSTRACT Objective: To advance the understanding of KCNQ2 encephalopathy genotype–phenotype relationships and to begin to assess the potential of selective KCNQ channel openers as targeted treatments. Methods: We retrospectively(More)
  • 1